Vertex Pharmaceuticals (VRTX)

$219.37 3.88 (1.74%)

16:27 EST VRTX Stock Quote Delayed 15 Minutes

Volume:

Previous Close $223.25

Market Cap 55.90B

PE Ratio 255.08

EPS 0.86

Volume (Avg. Vol.) 1.77M

Day's Range 219.19 - 225.66

52-Week Range 151.80 - 224.66

Dividend & Yield N/A (N/A)

VRTX Stock Predictions, Articles, and Vertex Pharmaceuticals News

From InvestorPlace
From the Web

Check Out These 5 Fast-Growing Stocks to Buy

By Louis Navellier, Editor, Growth Investor Nov 20, 2019

Growth is on a different track now, and here are some great ideas for stocks to buy to ride the momentum.

5 Biotech Stocks to Buy for a Strong Growth Prognosis

By Aaron Levitt, InvestorPlace Contributor Oct 25, 2019

The long term is rosy for these five biotech stocks. They have the pipelines, partners and marketed drugs to provide years of growth for investors.

5 Healthcare Stocks to Buy

By William Roth, InvestorPlace Market Strategist Oct 22, 2019

Healthcare in particular is one such sector, with a number of large-cap biotechnology and pharmaceutical stocks enjoying fresh rallies.

5 Large-Cap Stocks With Growth in the Tank

By Laura Hoy, InvestorPlace Contributor Oct 8, 2019

Investors looking for the safety of large-cap stocks alongside impressive growth should consider these five investments.

3 Big Stock Charts for Friday: Conagra Brands, HollyFrontier and Vertex Pharmaceuticals

By James Brumley, InvestorPlace Feature Writer Sep 27, 2019

The stock charts of CAG, VRTX and HFC are poised to end the trading week in pivotal situations. Here's what you should know about each.

5 Goldman Sachs Stocks to Buy With Over 20% Upside Potential

By Harriet Lefton, Writer, TipRanks Sep 17, 2019

Here we take a closer look at five stocks with bullish calls from Goldman Sachs. As you will see, each of these stocks shows over 20% upside potential from current levels.

Compare Brokers

3 Big Stock Charts for Tuesday: TechnipFMC PLC, Vertex Pharmaceuticals and Constellation Brands

By James Brumley, InvestorPlace Feature Writer Aug 27, 2019

The stock charts of FTI, VRTX and STZ are knocking on the doors of major moves, even if the broad market isn't.

4 Biotech Stocks Sliding Lower

By William Roth, InvestorPlace Market Strategist Jul 26, 2019

Biotech stocks have been looking rough lately, and these four names have been helping to lead the charge lower.

3 Big Stock Charts for Friday: HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals

By James Brumley, InvestorPlace Feature Writer Jul 12, 2019

The stock charts of HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals are poised to end the trading week in a pivotal situation.

10 Stocks That Are Screaming Buys Right Now

By Harriet Lefton, Writer, TipRanks Jun 27, 2019

Even in these unstable times, there are still gems to be found. And these are 10 of the hottest stocks on the Street, complete with "strong buy" analyst ratings and some compelling growth drivers.

7 Top-Rated Biotech Stocks to Invest In Today

By Louis Navellier, Editor, Growth Investor Jun 14, 2019

Despite the trade dispute with China, these biotech stocks each earn top marks in Portfolio Grader for fundamentals, earnings and momentum.

3 Big Stock Charts for Friday: Symantec, Vertex Pharmaceuticals and Nektar Therapeutics

By James Brumley, InvestorPlace Feature Writer Jun 14, 2019

Stock charts of VRTX, NKTR and SYMC are going to end the trading week knocking on the door of major moves.

Compare Brokers

5 Growthy Biotech Stocks to Buy Despite the Scrutiny

By Chris Lau, InvestorPlace Contributor May 13, 2019

Government is scrutinizing the drug development and approval process and creating uncertainties among biotech stocks. Time to buy?

7 Stocks to Buy From the T. Rowe Price Health Sciences Fund

By Will Ashworth, InvestorPlace Contributor May 6, 2019

One of the best mutual funds last year was the T. Rowe Price Health Sciences Fund. Here are 7 healthcare stocks to buy from its holdings.

5 Biotech Stocks for a Long-Lived Portfolio

By Chris Lau, InvestorPlace Contributor Apr 30, 2019

Biotech stocks fell sharply in the last few weeks, mostly on no new news. This drop may have created an entry point for investors.

The 10 Fastest-Growing Stocks to Invest In Right Now

By James Brumley, InvestorPlace Feature Writer Apr 9, 2019

Put these fast-growing stocks on your radar, if not in your portfolio, as your best shot at overcoming the market's summertime blues.

10 Strong Buy Stocks Trading at Killer Entry Points

By Harriet Lefton, Writer, TipRanks Dec 19, 2018

The market volatility isn't all bad! Now investors can find stocks to buy at killer entry points --determined by the Street's stop analysts.

10 Stocks That Can Move Higher Whatever Happens

By Harriet Lefton, Writer, TipRanks Dec 12, 2018

Morgan Stanley says these stocks are set to outperform even if the market slows down in 2019. That makes these 10 excellent stocks to buy for careful investors.

Compare Brokers

3 High-Reward Stocks From 3 Emerging Trends

By Matt McCall, Editor, MoneyWire Oct 12, 2018

These three high-reward stocks, each with their own emerging trend, that have huge upside potential in the transformative years ahead.

4 of the Best U.S. Stocks to Buy Today for Long-Term Growth

By Will Healy, InvestorPlace Contributor Jul 24, 2018

These four stocks are among the best U.S. stocks to buy today, as they beat S&P 500 growth rates in the past and should maintain strong growth rates in the years ahead.

Navellier Ratings

Total Grade

Buy

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!

Premium Services

We are always here to help!

Not Yet a Subscriber?

Welcome

Welcome

Vertex Pharmaceuticals (VRTX)

Navellier Ratings

Total Grade

10 Stocks Set for Monster Growth

Premium Services

We are always here to help!

Not Yet a Subscriber?

Welcome

Already a subscriber?

Welcome

Vertex Pharmaceuticals (VRTX)

VRTX Stock Predictions, Articles, and Vertex Pharmaceuticals News

Navellier Ratings

Total Grade

10 Stocks Set for Monster Growth

Subscriber Sign in